PubMed:32712670 / 4542-4701 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T152","span":{"begin":9,"end":18},"obj":"CHEBI:31781"},{"id":"T153","span":{"begin":9,"end":18},"obj":"DG_23"},{"id":"T154","span":{"begin":9,"end":18},"obj":"CHEBI:31781"},{"id":"T155","span":{"begin":56,"end":65},"obj":"GO:0007565"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Although lopinavir is no longer a first-line regimen in pregnancy, it remains an alternate regimen and is often the only PI available in low resource settings."}

{"project":"Inflammaging","denotations":[{"id":"T37","span":{"begin":0,"end":159},"obj":"Sentence"},{"id":"T37","span":{"begin":0,"end":159},"obj":"Sentence"}],"text":"Although lopinavir is no longer a first-line regimen in pregnancy, it remains an alternate regimen and is often the only PI available in low resource settings."}